Value proposition

Integrated and agile biotech hub-and-spoke company

Landmark BioVentures AG (LBV), founded in 2021 and headquartered in Basel, Switzerland, is an integrated and agile biotech hub-and-spoke company. LBV takes a unique model focused on lean operations, smart capital allocation, and diversified yet complementary nexus of seven companies developing 10 first in class therapeutics.

drug development , biotech, oncology, immuno-oncology, ophthalmology, immunology, pathobiology, inflammation, and business development